Société de Therapeutique Marocaine S.A. - Income Statement (TTM)

Société de Therapeutique Marocaine S.A.
MA ˙ CBSE
Income Statement (TTM)

Société de Therapeutique Marocaine S.A. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
Revenue 1,737 1,798 1,869 1,940 1,998 2,056 2,145 2,233 2,268 2,302 2,319 2,336 2,411 2,486 2,558 2,630 2,723 2,816
Change (%) 3.53 3.95 3.80 2.99 2.90 4.32 4.14 1.53 1.51 0.74 0.74 3.21 3.11 2.89 2.81 3.54 3.42
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 879 914 958 1,003 1,019 1,035 1,075 1,114 1,159 1,203 1,222 1,240 1,288 1,335 1,388 1,441 1,465 1,488
Change (%) 4.02 4.84 4.62 1.63 1.60 3.81 3.67 3.99 3.84 1.54 1.52 3.82 3.68 3.98 3.82 1.63 1.60
% of Revenue 50.60 50.84 51.28 51.68 51.00 50.36 50.11 49.89 51.10 52.27 52.68 53.09 53.41 53.70 54.27 54.81 53.79 52.85
Gross Operating Profit 858 884 911 937 979 1,021 1,070 1,119 1,109 1,099 1,097 1,096 1,123 1,151 1,170 1,188 1,258 1,328
Change (%) 3.03 3.03 2.94 4.44 4.25 4.83 4.61 -0.92 -0.93 -0.13 -0.13 2.52 2.46 1.63 1.60 5.86 5.54
% of Revenue 49.40 49.16 48.72 48.32 49.00 49.64 49.89 50.11 48.90 47.73 47.32 46.91 46.59 46.30 45.73 45.19 46.21 47.15
SG&A 448 471 492 513 528 542 557 572 588 605 621 638 661 683 683 682 706 731
Change (%) 5.34 4.45 4.26 2.82 2.75 2.72 2.64 2.87 2.79 2.73 2.65 3.58 3.46 -0.08 -0.08 3.54 3.42
% of Revenue 25.77 26.22 26.35 26.47 26.42 26.38 25.98 25.60 25.94 26.27 26.79 27.30 27.40 27.49 26.70 25.95 25.95 25.95
R&D
Change (%)
% of Revenue
OpEx 1,339 1,402 1,459 1,516 1,556 1,596 1,657 1,718 1,768 1,819 1,865 1,911 2,001 2,091 2,152 2,214 2,250 2,286
Change (%) 4.77 4.04 3.88 2.67 2.60 3.80 3.66 2.95 2.87 2.52 2.45 4.72 4.51 2.94 2.85 1.63 1.61
% of Revenue 77.08 78.00 78.07 78.13 77.88 77.65 77.27 76.91 77.99 79.03 80.42 81.79 82.99 84.11 84.15 84.19 82.64 81.19
Operating Income 398 395 410 424 442 459 488 516 499 483 454 425 410 395 405 416 473 530
Change (%) -0.65 3.64 3.52 4.14 3.98 6.12 5.77 -3.20 -3.31 -5.94 -6.31 -3.57 -3.70 2.63 2.56 13.72 12.06
% of Revenue 22.92 22.00 21.93 21.87 22.12 22.35 22.73 23.09 22.01 20.97 19.58 18.21 17.01 15.89 15.85 15.81 17.36 18.81
Interest Expense -11 -11 -11 -11 -10 -9 -9 -10 -10 -10 -11 -13 -16 -20 -23 -26 -29 -31
Change (%) -0.33 -1.46 -1.48 -7.33 -8.68 2.98 2.89 1.57 2.32 12.43 11.05 31.35 23.86 14.46 12.63 9.44 8.63
% of Revenue -0.64 -0.62 -0.58 -0.55 -0.50 -0.44 -0.44 -0.43 -0.43 -0.44 -0.49 -0.54 -0.68 -0.82 -0.91 -1.00 -1.06 -1.11
Net Income 233 230 240 249 264 279 293 306 286 267 264 260 262 263 269 274 295 315
Change (%) -1.10 4.12 3.96 5.95 5.62 4.91 4.68 -6.47 -6.92 -1.17 -1.18 0.46 0.45 2.22 2.17 7.45 6.93
% of Revenue 13.40 12.80 12.83 12.85 13.21 13.56 13.64 13.71 12.63 11.58 11.36 11.15 10.85 10.57 10.50 10.44 10.83 11.20

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista